Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
36.33
-0.56 (-1.52%)
At close: Mar 25, 2026, 4:00 PM EDT
36.50
+0.17 (0.47%)
After-hours: Mar 25, 2026, 7:59 PM EDT
Novo Nordisk (NVO) Revenue by Segment
History
| Date | Diabetes | Obesity | Rare Disease |
|---|---|---|---|
| Sep 30, 2025 | 33.30B | 12.63B | 3.10B |
| Jun 30, 2025 | 33.11B | 12.28B | 3.08B |
| Mar 31, 2025 | 32.90B | 11.27B | 2.93B |
| Dec 31, 2024 | 32.10B | 10.12B | 2.90B |
| Sep 30, 2024 | 30.78B | 8.54B | 2.72B |
| Jun 30, 2024 | 29.95B | 7.52B | 2.62B |
| Mar 31, 2024 | 28.35B | 6.96B | 2.64B |
| Dec 31, 2023 | 26.95B | 6.47B | 2.67B |
| Sep 30, 2023 | 25.04B | 5.58B | 2.71B |
| Jun 30, 2023 | 24.04B | 4.35B | 2.90B |
| Mar 31, 2023 | 22.88B | 3.31B | 3.07B |
| Dec 31, 2022 | 21.68B | 2.62B | 3.19B |
| Sep 30, 2022 | 20.66B | 2.15B | 3.17B |
| Jun 30, 2022 | 19.51B | 1.85B | 3.08B |
| Mar 31, 2022 | 18.52B | 1.59B | 3.04B |
| Dec 31, 2021 | 17.59B | 1.31B | 2.98B |
| Sep 30, 2021 | 16.41B | 1.11B | 2.95B |
| Jun 30, 2021 | 15.65B | 965.82M | 2.99B |
| Mar 31, 2021 | 15.33B | 880.37M | 2.96B |
| Dec 31, 2020 | 15.10B | 882.39M | 2.98B |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.